CHRD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Chord Energy Corp (CHRD) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock's technical indicators show an overbought condition, and recent financial performance has been weak with significant YoY declines in revenue, net income, and EPS. Additionally, analysts have been lowering price targets, and there are no recent positive news or catalysts to support a strong bullish case. While options data suggests bullish sentiment, the lack of recent trading signals and weak financials make this stock better suited for monitoring rather than immediate investment.
The technical indicators for CHRD show mixed signals. The MACD is positive and expanding, indicating bullish momentum. Moving averages are also bullish (SMA_5 > SMA_20 > SMA_200). However, the RSI is at 86.09, indicating the stock is overbought. The stock is trading near resistance levels (R1: 118.048, R2: 122.652), which may limit further upward movement in the short term.
Bullish technical indicators such as MACD and moving averages. Options data shows strong bullish sentiment. Historical stock trend analysis indicates a high probability of short-term gains, with an 80% chance of a 2.33% increase in the next day and 8.26% in the next week.
The RSI indicates overbought conditions, suggesting limited short-term upside. Recent financial performance is weak, with significant YoY declines in revenue (-19.61%), net income (-59.96%), and EPS (-62.26%). Analysts have been lowering price targets, reflecting cautious sentiment. No recent news or significant insider/hedge fund activity to support a bullish case.
In Q4 2025, CHRD reported a 19.61% YoY drop in revenue to $1.17 billion. Net income fell 59.96% YoY to $83.99 million, and EPS dropped 62.26% YoY to $1.4. Gross margin also declined significantly to 16.86%, down 35.94% YoY. These figures indicate a challenging financial environment for the company.
Analysts have been lowering price targets for CHRD, reflecting cautious sentiment. Piper Sandler lowered the target to $151 from $160, Wells Fargo to $109 from $113, and Morgan Stanley to $114 from $123. Most analysts maintain Overweight or Buy ratings, but the downward revisions highlight concerns about oil market oversupply and weaker cash flow expectations.
